NO2393477T3 - - Google Patents

Info

Publication number
NO2393477T3
NO2393477T3 NO10705986A NO10705986A NO2393477T3 NO 2393477 T3 NO2393477 T3 NO 2393477T3 NO 10705986 A NO10705986 A NO 10705986A NO 10705986 A NO10705986 A NO 10705986A NO 2393477 T3 NO2393477 T3 NO 2393477T3
Authority
NO
Norway
Application number
NO10705986A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42153807&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2393477(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2393477T3 publication Critical patent/NO2393477T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO10705986A 2009-02-04 2010-02-03 NO2393477T3 (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/365,754 US20100196483A1 (en) 2009-02-04 2009-02-04 Method for treatmentof severe and uncontrollable asthma
PCT/EP2010/051321 WO2010089330A1 (en) 2009-02-04 2010-02-03 Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma

Publications (1)

Publication Number Publication Date
NO2393477T3 true NO2393477T3 (he) 2018-05-26

Family

ID=42153807

Family Applications (1)

Application Number Title Priority Date Filing Date
NO10705986A NO2393477T3 (he) 2009-02-04 2010-02-03

Country Status (22)

Country Link
US (1) US20100196483A1 (he)
EP (2) EP2393477B1 (he)
JP (1) JP5886630B2 (he)
KR (1) KR20110122671A (he)
CN (2) CN102307567A (he)
AU (1) AU2010210183B2 (he)
BR (1) BRPI1008227A8 (he)
CA (1) CA2751443C (he)
DK (1) DK2393477T3 (he)
ES (1) ES2659328T3 (he)
HU (1) HUE038553T2 (he)
IL (1) IL213959A (he)
MX (1) MX2011008200A (he)
NO (1) NO2393477T3 (he)
NZ (1) NZ594210A (he)
PL (1) PL2393477T3 (he)
PT (1) PT2393477T (he)
RU (1) RU2519344C2 (he)
SG (1) SG173538A1 (he)
SI (1) SI2393477T1 (he)
UA (1) UA102587C2 (he)
WO (1) WO2010089330A1 (he)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5570996B2 (ja) 2007-12-14 2014-08-13 エアロデザインズ インコーポレイテッド エアロゾル化可能な食料品の送達
CN104271187B (zh) 2012-03-09 2018-01-12 维克多瑞有限责任公司 吸入装置的混合通道与吸入装置
WO2014012954A1 (en) * 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
WO2014150245A1 (en) * 2013-03-15 2014-09-25 Aradigm Corporation Methods for inhalation of smoke-free nicotine
US8807131B1 (en) 2013-06-18 2014-08-19 Isonea Limited Compliance monitoring for asthma inhalers
US10307370B2 (en) 2013-10-08 2019-06-04 AI Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
US20160339010A1 (en) * 2014-01-22 2016-11-24 Takeda Gmbh Treatment of Partly Controlled or Uncontrolled Severe Asthma
DK3125875T3 (da) * 2014-04-04 2023-07-24 Ai Therapeutics Inc Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
MX390453B (es) * 2014-06-25 2025-03-19 Optinose Inc Administracion nasal.
KR20170095807A (ko) 2014-10-07 2017-08-23 램 테라퓨틱스, 인코포레이티드 폐 고혈압의 치료를 위한 흡입가능 라파마이신 제제
RU2611406C1 (ru) * 2015-09-03 2017-02-21 Общество с ограниченной ответственностью "Биосурф" (ООО "Биосурф") Способ лечения бронхиальной астмы
ES2988939T3 (es) 2016-07-08 2024-11-22 Trudell Medical Int Inc Dispositivo de presión espiratoria positiva oscilante inteligente
JP7093353B2 (ja) 2016-12-09 2022-06-29 トゥルーデル メディカル インターナショナル スマートネブライザ
AU2019205865B2 (en) 2018-01-04 2024-11-28 Trudell Medical International Inc. Smart oscillating positive expiratory pressure device
AU2020338979B2 (en) 2019-08-27 2025-09-25 Trudell Medical International Inc. Smart oscillating positive expiratory pressure device
US11593679B2 (en) * 2019-11-29 2023-02-28 Kpn Innovations, Llc. Method of and system for generating a longevity element and an instruction set for a longevity element plan
US12051492B2 (en) * 2021-01-29 2024-07-30 AsthmaTek, Inc. Systems and methods to determine a therapy regimen to treat asthma of a subject

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19720701A1 (de) * 1997-05-16 1998-11-19 Gsf Forschungszentrum Umwelt Vorrichtung zur Applikation eines Medikament-Aerosols über die Lunge
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
DE19851279B4 (de) * 1998-06-17 2006-05-24 GSF - Forschungszentrum für Umwelt und Gesundheit GmbH Vorrichtung zum gesteuerten inhalatorischen Einbringen von dosierten Medikamenten in die Lunge
DE19912265A1 (de) * 1999-03-18 2000-09-21 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zur Bereitstellung einer konstanten Medikamenten-Dosis für eine inhalatorische Applikation mit niedrigem Inhalationsfluß
DE19912461B4 (de) * 1999-03-19 2006-07-20 GSF - Forschungszentrum für Umwelt und Gesundheit GmbH Vorrichtung zur Flußbegrenzung bei niedrigen Differenzdrücken
DE10013093B4 (de) * 2000-03-17 2005-12-22 Inamed Gmbh Vorrichtung zur kontrollierten Inhalation therapeutischer Aerosole
DE10029119B4 (de) * 2000-06-14 2005-12-22 Institut für Aerosol Medizin InAMed GmbH Inhalationsvorrichtung
DE10123749A1 (de) * 2001-05-16 2002-12-12 Inamed Gmbh Vorrichtung zum Verabreichen von Aerosolen
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
RU2006127432A (ru) * 2003-12-31 2008-02-10 Сайдекс, Инк. (Us) Ингаляционная композиция, содержащая сульфоалкиловый эфир циклодекстрина и кортикостероид, полученная из единичной дозы суспензии
EP1700614B1 (de) * 2005-03-08 2013-05-08 Activaero GmbH Inhalationsvorrichtung
DE502005001542D1 (de) * 2005-07-06 2007-10-31 Activaero Gmbh Regelbares Ventil und Inhalationsvorrichtung
KR100802292B1 (ko) * 2006-07-21 2008-02-11 동부일렉트로닉스 주식회사 마스크 및 이를 이용한 마이크로 렌즈 제작 방법
EP2173169B1 (en) * 2007-06-28 2014-05-21 CyDex Pharmaceuticals, Inc. Nasal delivery of aqueous corticosteroid solutions
EP2344126A1 (en) * 2008-10-14 2011-07-20 Activaero GmbH Method for treatment of copd and other pulmonary diseases

Also Published As

Publication number Publication date
JP5886630B2 (ja) 2016-03-16
IL213959A0 (en) 2011-08-31
CA2751443A1 (en) 2010-08-12
CN102307567A (zh) 2012-01-04
HUE038553T2 (hu) 2018-10-29
IL213959A (he) 2015-05-31
BRPI1008227A8 (pt) 2018-12-11
EP3338782A1 (en) 2018-06-27
MX2011008200A (es) 2011-10-21
RU2011135824A (ru) 2013-03-10
SI2393477T1 (en) 2018-04-30
KR20110122671A (ko) 2011-11-10
CN104306360A (zh) 2015-01-28
JP2012516873A (ja) 2012-07-26
SG173538A1 (en) 2011-09-29
CA2751443C (en) 2018-03-20
NZ594210A (en) 2013-09-27
EP2393477A1 (en) 2011-12-14
UA102587C2 (ru) 2013-07-25
ES2659328T3 (es) 2018-03-14
RU2519344C2 (ru) 2014-06-10
PT2393477T (pt) 2018-02-14
US20100196483A1 (en) 2010-08-05
EP2393477B1 (en) 2017-12-27
WO2010089330A1 (en) 2010-08-12
AU2010210183B2 (en) 2014-09-11
PL2393477T3 (pl) 2018-06-29
BRPI1008227A2 (pt) 2016-03-08
DK2393477T3 (en) 2018-04-09
AU2010210183A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
BE2015C040I2 (he)
BRPI0925311A2 (he)
BR112012003062A2 (he)
BRPI0924307A2 (he)
BRPI1006562A2 (he)
BR112012012396A2 (he)
BR112012000607A2 (he)
BR122021004633A2 (he)
BR112012000665A2 (he)
BR112012012487A2 (he)
BR112012003080A2 (he)
BR112012003853A2 (he)
BRPI0924534A2 (he)
BR112012012080A2 (he)
BRPI1005795A2 (he)
BR112012001263A2 (he)
BR112012007656A2 (he)
BRPI1004942A2 (he)
BRPI1005817A2 (he)
BR112012000159A2 (he)
BR112012014856A2 (he)
BR112012007654A2 (he)
BR112012000255A2 (he)
BR112012007672A2 (he)
NO2393477T3 (he)